Literature DB >> 6293036

A successful eradication campaign. Global eradication of smallpox.

F Fenner.   

Abstract

Smallpox was the first important disease to be eradicated; it was the success of the Smallpox Eradication Programme that inspired this conference. Several biological reasons favored the eradication of smallpox, the most important of which were probably that recurrent infectivity did not occur, that there was no animal reservoir, and that an effective stable vaccine was available. The importance of smallpox as a disease that travelers might import into countries free of smallpox provided a powerful stimulus for its global eradication. This paper highlights some of the problems associated with the eradication of smallpox in two countries where eradication was difficult, India and Ethiopia, and the measures adopted to overcome the problems. The paper also stresses the importance of the development of methods for the certification of smallpox eradication from countries, from regions, and finally from the whole world. It is noted that close links between field work and research were important throughout the eradication campaign.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6293036     DOI: 10.1093/clinids/4.5.916

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  40 in total

1.  On the acceptability of biopharmaceuticals.

Authors:  Raymond Spier
Journal:  Sci Eng Ethics       Date:  1996-07       Impact factor: 3.525

2.  New generation of cell culture assay for smallpox vaccine potency.

Authors:  Isabelle Leparc-Goffart; Bertrand Poirier; Annie El Zaouk; Marie-Hélène Tissier; Florence Fuchs
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

3.  Synthesizing epidemiological and economic optima for control of immunizing infections.

Authors:  Petra Klepac; Ramanan Laxminarayan; Bryan T Grenfell
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-08       Impact factor: 11.205

4.  Vaccinia reporter viruses for quantifying viral function at all stages of gene expression.

Authors:  Daniel K Rozelle; Claire Marie Filone; Ken Dower; John H Connor
Journal:  J Vis Exp       Date:  2014-05-15       Impact factor: 1.355

5.  Identification of a pyridopyrimidinone inhibitor of orthopoxviruses from a diversity-oriented synthesis library.

Authors:  Ken Dower; Claire Marie Filone; Erin N Hodges; Zach B Bjornson; Kathleen H Rubins; Lauren E Brown; Scott Schaus; Lisa E Hensley; John H Connor
Journal:  J Virol       Date:  2011-12-28       Impact factor: 5.103

6.  Variola virus immune evasion design: expression of a highly efficient inhibitor of human complement.

Authors:  Ariella M Rosengard; Yu Liu; Zhiping Nie; Robert Jimenez
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

7.  Identifying and characterizing places for the targeted control of heterosexual HIV transmission in urban areas.

Authors:  Sarah Polk; Jonathan M Ellen; Caroline Fichtenberg; Steven Huettner; Meredith Reilly; Jenita Parekh; Jacky M Jennings
Journal:  AIDS Behav       Date:  2014-08

Review 8.  Smallpox vaccines for biodefense.

Authors:  Richard B Kennedy; Inna Ovsyannikova; Gregory A Poland
Journal:  Vaccine       Date:  2009-11-05       Impact factor: 3.641

9.  Impact of distinct poxvirus infections on the specificities and functionalities of CD4+ T cell responses.

Authors:  Nicholas A Siciliano; Adam R Hersperger; Aimee M Lacuanan; Ren-Huan Xu; John Sidney; Alessandro Sette; Luis J Sigal; Laurence C Eisenlohr
Journal:  J Virol       Date:  2014-06-25       Impact factor: 5.103

10.  Long-term T cell memory to human leucocyte antigen-A2 supertype epitopes in humans vaccinated against smallpox.

Authors:  N D Ostrout; M M McHugh; D J Tisch; A M Moormann; V Brusic; J W Kazura
Journal:  Clin Exp Immunol       Date:  2007-05-04       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.